Precigen, Inc.
USD5.92
+0.06 (+1.02%)
CEO
Helen Sabzevari
IPO Date
2013-08-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.89
Prev. Close
$5.86
Day Low
$5.74
Day High
$6.04
52W Low
$1.40
52W High
$6.04
Market Cap
$1.78B
Volume
6.17M
| -2.4 |
| 31 Dec 2023 | FY | 1.7% | -1540.6% | -80.9% | -63.5% | 0.06 | 2.99 | -3.4 |
| 31 Dec 2022 | FY | 76.4% | 105.2% | 22.4% | 13.1% | 0.41 | 1.50 | 10.8 |
| 31 Dec 2021 | FY | -276.2% | -646.0% | -85.9% | -25.6% | 1.77 | 4.52 | -8.0 |
| 31 Dec 2020 | FY | -40.0% | -533.0% | -253.8% | -54.2% | 2.71 | 3.54 | -10.0 |
| 31 Dec 2019 | FY | 83.2% | -533.0% | -237.8% | -37.4% | 3.24 | 1.91 | -5.0 |
| 31 Dec 2018 | FY | 60.6% | -317.2% | -140.4% | -71.1% | 0.58 | 4.64 | -1.7 |
| 31 Dec 2017 | FY | 72.8% | -50.7% | -21.9% | -13.8% | 0.02 | 1.92 | -11.8 |
| 31 Dec 2016 | FY | 67.7% | -97.7% | -33.3% | -19.7% | 0.02 | 3.33 | -15.2 |
| -13.9 |
| 30 Sept 2025 | Q3 | 53.7% | -5008.4% | -349.5% | -85.4% | 2.35 | 4.04 | -1.7 |
| 30 Jun 2025 | Q2 | -81.7% | -3112.4% | 72.4% | -26.1% | -0.14 | 2.71 | -3.9 |
| 31 Mar 2025 | Q1 | -5.8% | -4038.3% | 385.2% | -42.0% | -0.39 | 3.53 | -2.0 |
| 31 Dec 2024 | Q4 | 1.8% | -1657.7% | -51.2% | -13.6% | 0.14 | 4.76 | -4.2 |
| 30 Sept 2024 | Q3 | -5.9% | -2516.1% | -43.3% | -28.7% | 0.10 | 1.63 | -2.7 |
| 30 Jun 2024 | Q2 | -41.4% | -8199.7% | -136.2% | -80.4% | 0.15 | 1.03 | -1.7 |
| 31 Mar 2024 | Q1 | -76.1% | -2228.9% | -24.5% | -17.6% | 0.07 | 1.72 | -3.8 |
| 31 Dec 2023 | Q4 | -109.0% | -2691.9% | -27.9% | -21.9% | 0.06 | 2.99 | -2.5 |